You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 144 No. 5, May 1984 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ORIGINAL INVESTIGATIONS
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (26)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Use of Nifedipine as an Adjunct to Current Antihypertensive Therapy

M. Grayson Evans, Jr, MD; Lawrence S. Olanoff, MD, PhD; Gilbert Hurwitz, MD, FRCP(C); T. Douglas Cowart, PharmD; Edward C. Conradi, MD

Arch Intern Med. 1984;144(5):985-987.


Abstract



• Ten hypertensive patients with poor responses to standard antihypertensive therapy were treated with the calcium channel antagonist nifedipine in an attempt to obtain better BP control. The drug was highly effective in significantly lowering BP immediately (average decrease, 58/29 mm Hg) and after three to eight weeks of maintenance therapy (average decrease, 49/27 mm Hg), with no significant change in heart rate observed at either time. No adverse interactions between nifedipine and other concurrent medications, including digoxin and β-adrenergic blockers, were noted. Drug-related side effects of tachycardia or flushing necessitated the withdrawal of nifedipine therapy in two patients. We conclude that nifedipine may be safely employed in an outpatient setting as a useful adjunct to current antihypertensive drug regimens.

(Arch Intern Med 1984;144:985-987)



Author Affiliations



From the Departments of Pharmacology (Drs Evans and Cowart) and Pharmacology and Medicine (Drs Olanoff, Hurwitz, and Conradi), Medical University of South Carolina, Charleston. Dr Evans is currently affiliated with the Department of Medicine, Roanoke (Va) Memorial Hospital, and Dr Hurwitz is currently affiliated with the Department of Nuclear Medicine, Barnes Hospital, St Louis.


Footnotes



Accepted for publication Oct 14, 1983.

Reprint requests to Department of Pharmacology, Medical University of South Carolina, Charleston, SC 29425 (Dr Conradi).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Is Sublingual Nifedipine Administration Superior to Oral Administration in the Active Treatment of Hypertension?
Diker et al.
ANGIOLOGY 1992;43:477-481.
ABSTRACT  

The Role of Calcium Channel Blockers in the Treatment of Essential Hypertension
Cummings et al.
Arch Intern Med 1991;151:250-259.
ABSTRACT  

Drugs Five Years Later: Nifedipine in Myocardial Ischemia, Systemic Hypertension, and Other Cardiovascular Disorders
ANN INTERN MED 1986;105:714-729.
ABSTRACT  

Hypertensive Crisis Associated With Nifedipine Withdrawal
Bursztyn et al.
Arch Intern Med 1986;146:397-397.
ABSTRACT  

Nifedipine in Antihypertensive Therapy
Bursztyn et al.
Arch Intern Med 1985;145:953-954.
ABSTRACT  

Nifedipine in the Treatment of Systemic Hypertension
Frishman and Charlap
Arch Intern Med 1984;144:2335-2336.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1984 American Medical Association. All Rights Reserved.